EN DE
Watch Amal Holdings for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Amal Holdings (AMAL) fair value: what the stock is really worth

As of Nov 4, 2026: fair value (intrinsic value) of Amal Holdings stock ILS 20.93, price ILS 14.81, upside +41.3%, quality 69 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare Il · ISIN IL0012320086

AH Amal Holdings logo Broad data Nov 5, 2026

Amal Holdings

AMAL · TA
Undervalued

The stock costs 29% less than our calculation considers fair.

Fair value 20.93 ILS · Undervalued (29%)
Quality 69/100
Healthy Growth (revenue YoY +13.3 %/yr in ILS)
Generates free cash flow
Broad data
Costs just 2.7 times its yearly profit.
Thin margins · 5.9% net margin (TTM)
Moderate debt
Mixed vs. peers (7/14)
Moderate moat 53/100 · thin data

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

20.25 ILS 14.41 ILS Fair Value 20.93 ILS Nov 2025 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.

How to read this chart

11‑month range 14.41 ILS – 20.25 ILS · fair‑value band 12.59 ILS – 27.21 ILS · the 14.81 ILS price screens below the 20.93 ILS fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.

Follow Amal in your weekly email

Every Wednesday you see whether Amal is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Amal Holdings A.D. Ltd. provides nursing, rehabilitation, and care services in Israel.

Show moreShow less

The company offers home care, senior housing, mental health, special education, and foster care; psychological treatment, counseling, diagnosis, and treatment; community mental health rehabilitation; consultation and preparation for insurance comities; preventive intervention for anxiety, distress, and post-traumatic stress services in children, as well as operates physiotherapy centers and educational frameworks.

Amal Holdings A.D. Ltd. was founded in 1984 and is based in Caesarea, Israel.

Stock analysis

Amal Holdings (AMAL) currently trades at 14.81 ILS, while our model-based Fair Value estimate is 20.93 ILS, implying the stock looks roughly 29% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 21.62 ILS per share, and 17 of the 26 models we run sit above the 14.81 ILS price.

Bear case: the Economic Profit group reads lowest at 4.30 ILS, and 9 of the 26 models stay below the price. Data coverage for this calculation is high.

Scenario range: 12.59 ILS (bear) to 27.21 ILS (bull), the price of 14.81 ILS sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 69/100 (solid quality), in the Healthcare sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Amal Holdings reported revenue of 2.2B ILS in FY2025 versus 1.6B ILS in FY2023, a compound +16.3%/yr. Reported net income was 134M ILS in FY2025, compounding +22.6%/yr from FY2023.

Key figures

Market cap 2.1B ILS Small · P/E ratio 2.7 · P/S ratio 0.17 · EPS (TTM) 5.39 ILS · Dividend yield 1.2% · Net margin 6.1% · Return on assets (EBIT) 19.3% · Operating margin 8.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 53 out of 100 (low confidence).

What moves the price

The share trades about 27% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at 41%, AMAL screens cheaper than that median.

Fair Value models

Bear 12.59 ILS Fair Value 20.93 ILS Bull 27.21 ILS
Price 14.81 ILS · Upside +41.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (4.41 ILS per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 12.59 ILS 21.62 ILS 36.27 ILS 71
EPV 6.33 ILS 7.20 ILS 7.90 ILS 71
Growth DCF 12.17 ILS 19.94 ILS 30.63 ILS 70
All 26 models by family
DCF Models
FCF DCF 12.59 ILS 21.62 ILS 36.27 ILS 71
Owner Earnings 11.07 ILS 19.47 ILS 32.15 ILS 67
5Y Revenue Exit 11.76 ILS 21.55 ILS 35.07 ILS 64
5Y EBITDA Exit 14.89 ILS 28.32 ILS 45.67 ILS 66
5Y P/E Exit 12.93 ILS 24.07 ILS 37.21 ILS 63
10Y Revenue Exit 11.52 ILS 20.11 ILS 33.72 ILS 59
10Y EBITDA Exit 13.61 ILS 24.36 ILS 41.46 ILS 60
10Y P/E Exit 12.50 ILS 21.70 ILS 35.28 ILS 56
Earnings-Based
Graham-Dodd 6.49 ILS 35.29 ILS 48.94 ILS 57
Lynch FV 9.79 ILS 13.99 ILS 18.19 ILS 55
PEG = 1.0 9.79 ILS 13.99 ILS 18.19 ILS 52
EPV 6.33 ILS 7.20 ILS 7.90 ILS 71
Dividend Discount
Gordon GGM 6.94 ILS 11.36 ILS 14.50 ILS 62
DDM Multi-Stage 6.94 ILS 10.90 ILS 12.25 ILS 61
Multiples
P/E Multiple 15.75 ILS 21.00 ILS 26.24 ILS 63
P/S Multiple 12.17 ILS 16.22 ILS 20.28 ILS 58
P/B Multiple 4.43 ILS 5.91 ILS 7.39 ILS 55
EV/EBIT 16.20 ILS 22.13 ILS 28.06 ILS 66
EV/EBITDA 17.77 ILS 24.22 ILS 30.68 ILS 67
EV/Revenue 11.11 ILS 16.55 ILS 21.99 ILS 53
Asset-Based
NCAV (Graham) 0.6600 ILS 0.8800 ILS 1.31 ILS 54
Growth DCF
Growth DCF 12.17 ILS 19.94 ILS 30.63 ILS 70
Rev-Margin DCF 11.76 ILS 21.29 ILS 34.23 ILS 64
Economic Profit
Residual Income 3.45 ILS 4.30 ILS 7.39 ILS 67
ROIC Compounder 7.08 ILS 8.88 ILS 10.87 ILS 66
Growth Earnings
Growth-Adj P/E 14.65 ILS 20.93 ILS 27.21 ILS 61

Open the full fair value analysis →

Quality Score breakdown

Overall quality 69/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 78
How much profit the company makes from its sales and capital
Quality Growth 63
Are margins and returns getting better?
Cashflow 61
Do the profits arrive as real cash?
Financial strength 28
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 76
How calm the share price moves, does not count
Price momentum 28
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 8
Distance to the 52-week high, does not count
New shares 80
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 89/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 2 usable fiscal years, at least 4 required
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+8.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Israel: IMF forecast 2.1% a year to 2030, 1.7% from 2016 to 2025) that is about +5.8% a year for the price.

Watch AMAL, get fair value alerts →

Compare Amal Holdings with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 236 stocks

Beats the industry median on 7/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 69 · Top 25%
Fair Value upside +41.3% · Above median
Profitability
Return on assets 13.5% · Top 25%
Net margin (12 months) 5.9% · Below median
Operating margin (12 months) 8.5% · Below median
Growth and dividend
Revenue growth (quarter YoY) 4.2% · Below median
Dividend yield (12 months) 1.2% · Below median
Balance sheet
Debt / equity 1.04× · Highest 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (12 months) 2.7× · Cheapest 25%
P/B 3.57× · Pricier than median
P/S (12 months) 0.29× · Cheapest 25%
Price / free cash flow 3.6× · Cheapest 25%
EV/EBITDA 3.7× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)88 · sector 36
FUTURE (revenue growth)21 · sector 29
PAST (return on equity)0 · sector 33
HEALTH (low debt)48 · sector 90
DIVIDEND (yield)24 · sector 40

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Aier Eye Hospital Group 300015 ¥8.92 ¥10.88 +22% vs AMAL
DaVita Inc DVA $192.66 $218.90 +14% vs AMAL
HCA Healthcare, Inc HCA $510.70 $547.34 +7% vs AMAL
Fresenius Medical Care AG FME €40.92 €39.20 −4% vs AMAL
Tenet Healthcare Corporation THC $292.25 $279.20 −4% vs AMAL
The Ensign Group ENSG $188.31 $140.09 −26% vs AMAL
Fresenius SE FRE €51.38 €34.56 −33% vs AMAL
Encompass Health Corporation EHC $141.03 $94.81 −33% vs AMAL
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,600 ₹5,234 −39% vs AMAL
Dr. Sulaiman Al Habib Medical Services Group 4013 213.40 SAR 109.45 SAR −49% vs AMAL

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Amal Holdings: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Amal Holdings Fair Value". https://www.fairvalue-calculator.com/stock/AMAL.TA

Frequently asked questions

Is Amal Holdings (AMAL) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of 20.93 ILS versus a price of 14.81 ILS, about +41% upside (undervalued).
What is the fair value of AMAL?
Our model-based fair value for Amal Holdings is 20.93 ILS (as of Nov 5, 2026), built from audited fundamentals. The current price: 14.81 ILS.
What is the quality score of AMAL?
Amal Holdings has a Quality Score of 69/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Amal Holdings (AMAL)?
Our model-based price target is the fair value of 20.93 ILS (as of Nov 5, 2026) from 26 valuation models. Cautious scenario 12.59 ILS, optimistic scenario 27.21 ILS. It is a calculation from audited fundamentals, not an analyst target.
What is the Amal Holdings stock forecast for 2026?
Our models put fair value at 20.93 ILS, about +41% upside versus a price of 14.81 ILS (undervalued). Cautious scenario 12.59 ILS, optimistic scenario 27.21 ILS. The calculation is refreshed regularly with new filings.
What is the revenue of Amal Holdings (AMAL)?
Amal Holdings reported trailing-twelve-month revenue of about 2.3B ILS (latest available figure, as of Nov 5, 2026).
Does Amal Holdings pay a dividend?
Amal Holdings currently shows a dividend yield of 1.21% relative to its recent price (as of Nov 5, 2026).
What growth is priced into Amal Holdings (AMAL)?
For today's price to be fair in a discounted-cash-flow model, Amal Holdings would have to grow free cash flow by +8.0 % per year for five years (discount rate 13.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 2 years revenue grew +16.3 % per year. As of Nov 5, 2026.
What discount rate (WACC) does the fair value of AMAL use?
Our models discount Amal Holdings at 13.1 %: a base by market capitalisation (small), country premium for Israel. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Amal Holdings that is +8.0 % per year a year over ten years, using the same discount rate (13.1 %) and the same formula as our fair value.
How much growth has Amal Holdings (AMAL) delivered so far?
Over the past 2 years revenue at Amal Holdings grew +16.3 % a year. The price currently implies +8.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Amal Holdings (AMAL) growing?
The median revenue growth in the sector is +1.7 % a year. That is the yardstick for the growth priced into Amal Holdings (+8.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Amal Holdings (AMAL)?
The free-cash-flow yield on the price is 8.84 %: that much free cash flow Amal Holdings produces per unit of market value. When it exceeds the discount rate of our models (13.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Amal Holdings (AMAL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Amal Holdings it is 20.93 ILS per share (as of Nov 5, 2026), against a price of 14.81 ILS. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Amal Holdings stock overvalued or undervalued in 2026?
As of Nov 5, 2026, AMAL trades below its calculated fair value: price 14.81 ILS, fair value 20.93 ILS, a gap of about +41% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AMAL?
No. The price is what the market pays today (14.81 ILS); the fair value is what the company's own numbers justify (20.93 ILS). For Amal Holdings the two are 6.12 ILS per share apart. That gap is exactly why we show both numbers side by side.
How much is Amal Holdings worth?
The market values Amal Holdings at about 2.1B ILS (market capitalisation, as of Nov 5, 2026). Per share that is 14.81 ILS; our models calculate a fair value of 20.93 ILS per share.
What do the bullish and bearish scenarios say about AMAL?
Our models span a range for Amal Holdings: cautious scenario 12.59 ILS, base 20.93 ILS, optimistic 27.21 ILS per share (as of Nov 5, 2026, price 14.81 ILS). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of AMAL?
Amal Holdings trades at a price-to-earnings ratio of 2.7 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 20.93 ILS is built from several models across several years. Other multiples: P/B 3.6, P/S 0.3, EV/EBITDA 3.7.
How solid is the balance sheet of Amal Holdings (AMAL)?
Balance-sheet figures for Amal Holdings (as of Nov 5, 2026): debt of 1.04 per unit of equity. They feed the Quality Score of 69/100, which measures business quality independently of the share price.
How far is AMAL from its 52-week high?
Amal Holdings trades at 14.81 ILS, about 27% below its 52-week high of 20.25 ILS and 3% above the low of 14.41 ILS (as of Nov 4, 2026). Distance from the high says nothing about value: that is what the fair value of 20.93 ILS is for.
Which stocks are comparable to Amal Holdings?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Amal Holdings stock attractive at the current price?
The data as of Nov 5, 2026: price 14.81 ILS, calculated fair value 20.93 ILS (+41%), Quality Score 69/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AMAL calculated?
We run Amal Holdings through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 20.93 ILS, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0% above its aggregate fair value. Amal Holdings currently trades 29% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Amal Holdings (AMAL)?
The closing price on Nov 4, 2026 was 14.81 ILS. Our model-based fair value is 20.93 ILS, about +41% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Amal Holdings right now?
Solid quality (69/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (12.59 ILS to 27.21 ILS) leaves room in how you read the outcome.

Key figures of Amal Holdings

How large is the market capitalisation of Amal Holdings (AMAL)?
The market capitalisation of Amal Holdings is 2.1B ILS. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Amal Holdings (AMAL)?
The price-to-sales ratio of Amal Holdings is 0.17 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Amal Holdings (AMAL)?
Earnings per share at Amal Holdings are 5.39 ILS (price ÷ EPS = P/E 2.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Amal Holdings (AMAL)?
The dividend yield of Amal Holdings is 1.2% (payout 3.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Amal Holdings (AMAL)?
The net margin of Amal Holdings is 6.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Amal Holdings (AMAL)?
On an EBIT basis the return on assets of Amal Holdings is 19.3% (avg 2y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Amal Holdings (AMAL)?
The operating margin of Amal Holdings is 8.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Amal Holdings (AMAL)?
Revenue at Amal Holdings is growing +4.2% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Amal Holdings (AMAL)?
Earnings per share at Amal Holdings are growing −8.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Amal Holdings (AMAL) carry?
The net debt of Amal Holdings is 222M ILS (fiscal year 2025, ≈ 1.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Amal Holdings in the live analysis

One click puts Amal Holdings on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.